ListarMIC - Artículos por tema "Safety"
Mostrando ítems 1-2 de 2
-
Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART.
Palacios-Muñoz, María Rosario
; Pérez Hernández, Isabel Ascensión; Martínez, M.A.; Mayorga, María Luisa; González-Doménech, Carmen María; Omar, Mohamed; Olalla, Julián; Romero, Alberto; Romero, J.M.; Pérez Camacho, Inés; Hernández-Quero, José; Santos-González, Jesús Leandro[et al.] (Springer, 2016-02-15)
We analysed the efficacy and safety of switching from a regimen based on nonnucleoside reverse transcriptase inhibitors (NNRTI) or integrase inhibitors (INI) to ABC/3TC + RPV in virologically suppressed HIV-infected patients. ... -
Safety and efficacy of dolutegravir plus rilpivirine in treatment-experienced HIV-Infected Patients: the DORIVIR study
Palacios-Muñoz, María Rosario; Mayorga, María Luisa; González-Doménech, Carmen María; Hidalgo Tenorio, Carmen; Gálvez, Carmen; Muñoz Medina, Leopoldo; de la Torre, Javier; Lozano, Ana; Castaño, Manuel; Omar, Mohamed; Santos-González, Jesús Leandro[et al.] (SAGE, 2018-01)
Objectives: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). Methods: Open-label, multicenter study including ...